<?xml version="1.0" encoding="UTF-8" ?>
<?xml-stylesheet type="text/xsl" href="http://www.icis.com/icisconnect/utility/FeedStylesheets/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><title>Chemical industry conversations</title><link>http://www.icis.com/icisconnect/forums/363.aspx</link><description>Have your say about what's happening in the chemical industry. </description><dc:language>en</dc:language><generator>CommunityServer 2008.5 SP2 (Build: 40407.4157)</generator><item><title>M&amp;A Outlook</title><link>http://www.icis.com/icisconnect/forums/thread/1656.aspx</link><pubDate>Fri, 15 Aug 2008 21:09:45 GMT</pubDate><guid isPermaLink="false">8e774857-1e25-4730-bdb9-310c4492ad3b:1656</guid><dc:creator>Joe Cool</dc:creator><slash:comments>0</slash:comments><comments>http://www.icis.com/icisconnect/forums/thread/1656.aspx</comments><wfw:commentRss>http://www.icis.com/icisconnect/forums/commentrss.aspx?SectionID=363&amp;PostID=1656</wfw:commentRss><description>&lt;p&gt;After Dow Chemical&amp;#39;s announcement of its $18.8bn acquisition of Rohm and Haas and Ashland&amp;#39;s plan to buy Hercules for $3.3bn, what might be coming next? Chemtura is keeping all its options on the table, including a sale.&amp;nbsp;But private equity remains hampered by the global credit crisis.&lt;/p&gt;
&lt;p&gt;Who could be sold, and what is the outlook for more chemical M&amp;amp;A?&lt;/p&gt;
&lt;p&gt;Opinions&amp;nbsp;wanted!&lt;/p&gt;
&lt;p&gt;Joe&lt;/p&gt;&lt;div style="clear:both;"&gt;&lt;/div&gt;</description></item></channel></rss>